510(k) Report

510(k) · Cleared

Cleared

Neotonus MS-101 Magnetic Muscle Stimulator System

K973929510(k) TraditionalCleared May 21, 1998218-day reviewClass II21 CFR 890.5850

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Neotonus, Inc. · IPF Stimulator, Muscle, Powered

Cleared on May 21, 1998 after a 218-day review. The FDA summary names its predicate without a number. 21 later devices descend from it.

Decided
May 21, 1998
Review
218 days
Class
Class II
Product code
IPF
Recalls
None
Predicates
0

21 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2023: 3 descendants cleared2016: 1 descendant cleared2021: 4 descendants cleared2019: 1 descendant cleared2025: 4 descendants cleared2020: 1 descendant cleared2024: 4 descendants cleared2026: 3 descendants cleared1995200020052010201520202025
  1. This deviceK973929 Neotonus MS-101 Magnetic Muscle Stimulator SystemNeotonus, Inc. · 1998
  2. Descendant · cites it directly · 18 of its ownK160992 HPM-6000BTL Industries, Inc. · 2016
  3. Descendant · 2 generations on · 11 of its ownK190456 BTL 799-2LBTL Industries, Inc. · 2019
  4. Descendant · 2 generations on · 4 of its ownK203710 Storz Medical MAGNETOLITH Muscle StimulatorStorz Medical AG · 2021
  5. Descendant · 3 generations on · 4 of its ownK200382 BTL-703-2Btl · 2021
  6. Descendant · 2 generations on · 3 of its ownK203488 emFieldZimmer Medizinsysteme GmbH · 2021

Showing 5 of 21 descendants. See all descendants

Descendants cleared per year

2016: 12019: 12020: 12021: 42023: 32024: 42025: 42026: 3
2016high 4 (2021) · low 0 (2017)2026

Most influential descendants

Showing 5 of 21 · See all
  • K160992HPM-6000BTL Industries, Inc. · 2016 · cites it directly18descendants
  • K190456BTL 799-2LBTL Industries, Inc. · 2019 · 2 generations on11descendants
  • K203710Storz Medical MAGNETOLITH Muscle StimulatorStorz Medical AG · 2021 · 2 generations on4descendants
  • K200382BTL-703-2Btl · 2021 · 3 generations on4descendants
  • K203488emFieldZimmer Medizinsysteme GmbH · 2021 · 2 generations on3descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K973929Neotonus MS-101 Magnetic Muscle Stimulator SystemNeotonus, Inc.1998—
+1K160992HPM-6000BTL Industries, Inc.2016—
+2K190456BTL 799-2LBTL Industries, Inc.2019—
+2K203710Storz Medical MAGNETOLITH Muscle StimulatorStorz Medical AG2021—
+3K200382BTL-703-2Btl2021—
+2K203488emFieldZimmer Medizinsysteme GmbH2021—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201610
201910
202010
202140
202330
202440
202540
202630
FIG. 1 — Lineage of K973929, 1998–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in IPF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new IPF device

  1. #1 K241433 EVE Synergy (EVE-20M)score 19.7 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—RICH-MAR Theratouch electrical muscle stimulator
Named without a submission number
—

What descends from it? (21)

See all 21

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K160992HPM-6000BTL Industries, Inc.201618
K221274StarFormer, TightWaveFotona D.O.O.20231

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K160992 (BTL Industries, Inc., 2016) has gone furthest, with 18 descendants of its own.

How does its category compare?

All IPF devices

IPF Stimulator, Muscle, Powered: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · IPF

3in 2025

2007: 82008: 62009: 72010: 42011: 42012: 42013: 102014: 42015: 32016: 72017: 52018: 52019: 42020: 92021: 152022: 72023: 92024: 72025: 32026 (partial year): 3
2007high 15 (2021) · low 3 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · IPF

257in 2025

2007: 143 days median2008: 140 days median2009: 216 days median2010: 121 days median2011: 275 days median2012: 269 days median2013: 180 days median2014: 264 days median2015: 43 days median2016: 113 days median2017: 110 days median2018: 73 days median2019: 133 days median2020: 121 days median2021: 98 days median2022: 108 days median2023: 255 days median2024: 201 days median2025: 257 days median2026 (partial year): 206 days median
2007high 275 (2011) · low 43 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · IPF

1in 2023

2008: 12011: 12012: 32023: 1
2007high 3 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · IPF

8in 2025

2007: 112008: 2132009: 1502010: 142011: 252012: 162013: 62014: 192015: 112016: 82017: 22018: 32019: 102020: 132021: 32022: 42023: 82024: 52025: 8
2007high 213 (2008) · low 2 (2017)2025

MAUDE reports naming product code IPF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078143011
200861401213
200972160150
20104121014
20114275125
20124269316
20131018006
20144264019
2015343011
2016711308
2017511002
201857303
20194133010
20209121013
2021159803
2022710804
2023925518
2024720105
2025325708
202632060—

What is it indicated for?

The Neotonus MS-101 Magnetic Muscle Stimulator System is intended to be used under medical supervision for adjunctive therapy for the treatment of medical diseases and conditions.

The Neotonus MS-101 is indicated {v1 use in sumulating neuromuscular tissucs for bulk muscle excitation in the legs or arms for rehabilitative purposes.

Indications for Use for Muscle Stimulators:

Relaxation of muscle spasms

Prevention or retardation of disuse atrophy

Increasing local blaod circulation

Muscle re-education

Immediate post-surgical stimulation of calf muscles 1o prevent venous thrombosis

Maintaining or increasing range of motion

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K973929: Neotonus MS-101 Magnetic Muscle Stimulator System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K973929

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026